COMMUNIQUÉS West-GlobeNewswire

LeMaitre Vascular Announces Preliminary Q3 2018 Results
04/10/2018
BURLINGTON, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 [...]
Insmed Extends Patent Protection in Japan to 2033
04/10/2018
New Patent Adds 7 ½ Years of Market Exclusivity in Japan BRIDGEWATER, N.J., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients [...]
Study Demonstrating Globus Medical’s Expandable Technology Improves Lordosis and Reduces Subsidence Awarded Best Paper at SMISS
04/10/2018
AUDUBON, Pa., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, announced today that a recent clinical study evaluating static versus expandable lateral [...]
Corvus Pharmaceuticals to Present Data on Lead Programs at the European Society for Medical Oncology (ESMO) 2018 Congress and the Society for Immunotherapy of Cancer (SITC) Annual Meeting
04/10/2018
BURLINGAME, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
KemPharm Announces Proposed Public Offering of Common Stock
04/10/2018
CORALVILLE, Iowa, Oct. 04, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced that it intends to [...]
Cutera Updates Full Year 2018 Revenue Guidance
04/10/2018
truSculpt ® iD Sets Company Record for New System Launch Earnings Call Scheduled for November 6 BRISBANE, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider [...]
GBT Announces New Employment Inducement Grants
04/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that, on October 1, 2018, the compensation committee of the Company’s board of directors [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada
04/10/2018
First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis) with Polyneuropathy – a rare and inherited disease OTTAWA and BOSTON and CARLSBAD, Calif., Oct. [...]
Akcea et Ionis annoncent l’homologation de TEGSEDIMC (inotersen pour injection) au Canada
04/10/2018
Le premier et le seul traitement de ce type pour les Canadiens atteints d’amylose héréditaire liée à la transthyrétine (hATTR) avec polyneuropathie, une maladie héréditaire rare OTTAWA et BOSTON et CARLSBAD, Californie [...]
Krystal Biotech to Present at Chardan Annual Genetic Medicines Conference
04/10/2018
PITTSBURGH, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Allscripts and Appriss Health Partner to Provide Access to Prescription Drug Monitoring Program Information and the NarxCare Substance Use Disorder Platform
04/10/2018
Integration will enable Allscripts ePrescribe and EHR users to gain access to critical information and insights within clinical workflows; improves patient safety and outcomes through Appriss Health’s PMP Gateway [...]
Paratek Announces Acceptance of European Marketing Authorization Application for Oral and Intravenous Omadacycline
04/10/2018
-- MAA submission for both community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) -- -- EMA decision expected second half of 2019 -- BOSTON, Oct. 04, 2018 (GLOBE [...]
Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants
04/10/2018
WALTHAM, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies, today announced that it intends to offer and sell shares [...]
AVROBIO, Inc. to Present at Chardan's 2nd Annual Genetic Medicines Conference
04/10/2018
CAMBRIDGE, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company developing gene therapies to potentially cure rare diseases with a single [...]
Chris Swanker Receives NADP Gabryl Award
04/10/2018
National Lifetime Achievement Award Honors Contributions to Dental Benefits Industry DALLAS, Oct. 04, 2018 (GLOBE NEWSWIRE) -- For his leadership during critical health care reform years, Chris Swanker, Chief Executive [...]
Alpha II Will Join Health Care Leaders from Across the Globe at Cerner Health Conference 2018
04/10/2018
Healthcare conference will host nearly 14,000 in Kansas City, Oct. 8-11 TALLAHASSEE, Fla., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of software-as-a-service (SaaS) solutions that support [...]
Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
04/10/2018
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) ( CSE: ATT ) ( OTC: ATTBF ) is pleased to announce that the research being done in conjunction [...]
Acasti Pharma Prices C$24 Million Underwritten Offering
04/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”) is pleased [...]

Pages